Rethink Bronchiectasis

RethinkBronchiectasis.com by Insmed Incorporated is a source of information and resources on bronchiectasis for healthcare professionals. Bronchiectasis is a chronic and progressive disease usually marked by permanent, abnormal dilation and persistent inflammation of the airways. There have long been unmet needs in bronchiectasis, though it affects approximately 450,000 people in the United States and more globally. Bronchiectasis is commonly associated with symptoms of chronic cough, daily sputum production, and recurrent infections. It initially presents with nonspecific symptoms that mimic more common conditions such as COPD or asthma, which experts believe often delays diagnosis or leads to misdiagnoses. Bronchiectasis also notably causes exacerbations in which patients experience the worsening of multiple symptoms, requiring a change in treatment. To disrupt the vicious vortex of disease progression, a comprehensive management approach is required, focusing on all 4 primary drivers of the disease: addressing chronic airway infection, reducing chronic airway inflammation—primarily neutrophilic, enhancing mucociliary clearance, and preventing further lung destruction. For more information about managing and treating bronchiectasis, visit RethinkBronchiectasis.com. © 2023 Insmed Incorporated. All Rights Reserved. Insmed is a trademark of Insmed Incorporated. All other trademarks are property of their respective owner. NP-BE-US-00156